Early blast clearance by remission induction therapy is a major independent prognostic factor for both achievement of complete remission and long-term outcome in acute myeloid leukemia: data from the German AML Cooperative Group (AMLCG) 1992 Trial (Q30741760)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Early blast clearance by remission induction therapy is a major independent prognostic factor for both achievement of complete remission and long-term outcome in acute myeloid leukemia: data from the German AML Cooperative Group (AMLCG) 1992 Trial |
scientific article |
Statements
1 reference
Early blast clearance by remission induction therapy is a major independent prognostic factor for both achievement of complete remission and long-term outcome in acute myeloid leukemia: data from the German AML Cooperative Group (AMLCG) 1992 Trial (English)
1 reference
Claudia Schoch
1 reference
Torsten Haferlach
1 reference
Wolfgang Hiddemann
1 reference
Wolfgang Kern
1 reference
Helmut Loffler
1 reference
Winfried Gassmann
1 reference
Achim Heinecke
1 reference
Maria Christina Sauerland
1 reference
Wolfgang Berdel
1 reference
Thomas Buchner
1 reference
28 June 2002
1 reference
1 reference
101
1 reference
64-70
1 reference
Identifiers
1 reference
1 reference